STOCK TITAN

Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2025

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Ispire Technology (NASDAQ: ISPR) reported its fiscal Q1 2025 results, ending September 30, 2024.

Revenue was $39.3 million, down from $42.9 million in Q1 2024, an 8.2% decrease.

Gross profit increased 13.2% to $7.7 million, with margins rising from 16.0% to 19.5%.

Total operating expenses rose 67.0% to $12.9 million, attributed to increased marketing, stock-based compensation, and bad debt expenses.

Net loss widened to ($5.6) million or ($0.10) per share, compared to ($1.3) million or ($0.02) per share in Q1 2024.

The company expanded its global reach through a 5-year master distributor agreement with ANDS for MENA and global duty-free markets.

As of September 30, 2024, Ispire had $37.7 million in cash and working capital of $16.6 million.

Ispire Technology (NASDAQ: ISPR) ha riportato i risultati del primo trimestre fiscale 2025, terminato il 30 settembre 2024.

I ricavi sono stati di 39,3 milioni di dollari, in calo rispetto ai 42,9 milioni di dollari del primo trimestre 2024, con una diminuzione dell'8,2%.

Il profitto lordo è aumentato del 13,2%, raggiungendo 7,7 milioni di dollari, con margini che sono saliti dal 16,0% al 19,5%.

Le spese operative totali sono aumentate del 67,0%, raggiungendo 12,9 milioni di dollari, a causa dell'incremento delle spese di marketing, della compensazione basata su azioni e delle spese per crediti inesigibili.

La perdita netta è aumentata a 5,6 milioni di dollari o 0,10 dollari per azione, rispetto ai 1,3 milioni di dollari o 0,02 dollari per azione nel primo trimestre 2024.

L'azienda ha ampliato la sua portata globale attraverso un accordo di distribuzione principale di 5 anni con ANDS per i mercati MENA e duty-free globali.

Al 30 settembre 2024, Ispire aveva 37,7 milioni di dollari in liquidità e un capitale circolante di 16,6 milioni di dollari.

Ispire Technology (NASDAQ: ISPR) informó sus resultados del primer trimestre fiscal 2025, que finalizó el 30 de septiembre de 2024.

Los ingresos fueron de 39,3 millones de dólares, frente a 42,9 millones de dólares en el primer trimestre de 2024, marcando una disminución del 8,2%.

La ganancia bruta aumentó un 13,2% a 7,7 millones de dólares, con márgenes que pasaron del 16,0% al 19,5%.

Los gastos operativos totales aumentaron un 67,0% a 12,9 millones de dólares, atribuible al aumento de gastos de marketing, compensación basada en acciones y gastos por deudas incobrables.

La pérdida neta se amplió a 5,6 millones de dólares o 0,10 dólares por acción, en comparación con 1,3 millones de dólares o 0,02 dólares por acción en el primer trimestre de 2024.

La empresa amplió su alcance global a través de un acuerdo de distribución maestro de 5 años con ANDS para los mercados MENA y globales libres de impuestos.

Al 30 de septiembre de 2024, Ispire tenía 37,7 millones de dólares en efectivo y un capital de trabajo de 16,6 millones de dólares.

아이스파이어 테크놀로지 (NASDAQ: ISPR)는 2024년 9월 30일로 종료된 2025 회계 연도 1분기 실적을 보고했습니다.

매출은 3930만 달러로 2024년 1분기의 4290만 달러에서 감소하여 8.2% 감소했습니다.

총 이익은 13.2% 증가하여 770만 달러를 기록했으며, 마진은 16.0%에서 19.5%로 상승했습니다.

운영 비용은 67.0% 증가하여 1290만 달러에 달했으며, 이는 마케팅 비용 증가, 주식 기반 보상 및 부실채권 비용에 기인합니다.

순손실은 560만 달러 또는 주당 0.10 달러로 확대되었으며, 이는 2024년 1분기의 130만 달러 또는 주당 0.02 달러에 비해 증가한 수치입니다.

회사는 MENA 및 글로벌 면세 시장을 위한 ANDS와 5년 마스터 유통업체 계약을 체결하여 글로벌 범위를 확대했습니다.

2024년 9월 30일 기준으로 아이스파이어는 3770만 달러의 현금과 1660만 달러의 운영자본을 보유하고 있었습니다.

Ispire Technology (NASDAQ: ISPR) a publié ses résultats pour le premier trimestre fiscal 2025, se terminant le 30 septembre 2024.

Le chiffre d'affaires s'élevait à 39,3 millions de dollars, en baisse par rapport à 42,9 millions de dollars au premier trimestre 2024, soit une diminution de 8,2 %.

Le bénéfice brut a augmenté de 13,2 % pour atteindre 7,7 millions de dollars, avec des marges passant de 16,0 % à 19,5 %.

Les dépenses d'exploitation totales ont augmenté de 67,0 % pour atteindre 12,9 millions de dollars, attribuées à l'augmentation des dépenses de marketing, de la compensation en actions et des créances douteuses.

La perte nette s'est élargie à 5,6 millions de dollars, soit 0,10 dollar par action, contre 1,3 million de dollars ou 0,02 dollar par action au premier trimestre 2024.

La société a élargi son empreinte mondiale grâce à un accord de distribution principal de 5 ans avec ANDS pour les marchés MENA et globaux hors taxes.

Au 30 septembre 2024, Ispire disposait de 37,7 millions de dollars en liquidités et d'un fonds de roulement de 16,6 millions de dollars.

Ispire Technology (NASDAQ: ISPR) hat die Ergebnisse des ersten Geschäftsjahresquartals 2025 bekannt gegeben, das am 30. September 2024 endete.

Der Umsatz betrug 39,3 Millionen US-Dollar, ein Rückgang von 42,9 Millionen US-Dollar im ersten Quartal 2024, was einem Rückgang von 8,2% entspricht.

Der Bruttogewinn stieg um 13,2% auf 7,7 Millionen US-Dollar, während die Margen von 16,0% auf 19,5% stiegen.

Die Gesamten Betriebskosten erhöhten sich um 67,0% auf 12,9 Millionen US-Dollar, was auf gestiegene Marketingkosten, aktienbasierte Vergütungen und Forderungsausfälle zurückzuführen ist.

Der Nettoverlust erhöhte sich auf 5,6 Millionen US-Dollar oder 0,10 US-Dollar pro Aktie, im Vergleich zu 1,3 Millionen US-Dollar oder 0,02 US-Dollar pro Aktie im ersten Quartal 2024.

Das Unternehmen hat seine globale Reichweite durch einen 5-Jahres-Mastervertragsvertrieb mit ANDS für die MENA- und globalen Duty-Free-Märkte erweitert.

Am 30. September 2024 hatte Ispire 37,7 Millionen US-Dollar in bar und 16,6 Millionen US-Dollar im Umlaufvermögen.

Positive
  • Gross profit increased 13.2% to $7.7 million.
  • Gross margin improved from 16.0% to 19.5%.
  • Expanded global reach through a 5-year master distributor agreement with ANDS.
Negative
  • Revenue decreased 8.2% to $39.3 million.
  • Total operating expenses increased 67.0% to $12.9 million.
  • Net loss widened to ($5.6) million from ($1.3) million.

Insights

The fiscal Q1 2025 results present a mixed picture. While revenue declined 8.2% to $39.3 million, gross profit increased 13.2% to $7.7 million with improved margins of 19.5%. However, concerning trends include:

  • Operating expenses surged 67% to $12.9 million
  • Net loss widened significantly to $5.6 million from $1.3 million
  • U.S. sales dropped sharply by $8.1 million

The strategic shift toward higher-quality customers and improved payment terms has impacted short-term revenue but could strengthen long-term fundamentals. The ANDS distribution agreement and I-80 cannabis product launch provide growth catalysts, though increased operating costs and wider losses warrant careful monitoring.

The geographical revenue shifts reveal important market dynamics. While U.S. sales declined sharply, European revenue grew by $2.1 million to $22.0 million and other regions, particularly South Africa ($2.9 million increase), showed strong growth. The 5-year ANDS agreement for MENA and duty-free markets represents significant expansion potential. The focus on age-gating technology and the I-80 cannabis production system demonstrates strategic positioning in regulatory compliance and operational efficiency. However, increased marketing expenses and higher bad debt provisions ($1.9 million) suggest aggressive expansion comes with elevated risks.

Gross Profit Increased 13.2% Year-Over-Year to $7.7 Million

Gross Margins increased to 19.5%, up from 16.0% in Fiscal Q1 2024

Expanded Global Reach through 5-Year Master Distributor Agreement with ANDS for MENA and Global Duty-Free Markets

LOS ANGELES, Nov. 11, 2024 /PRNewswire/ --  Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported results for the fiscal first quarter 2025, which ended on September 30, 2024, and anticipates filing its annual report on Form 10-Q with the U.S. Securities and Exchange Commission (the "SEC") on November 12, 2024.

Fiscal First Quarter 2025 Financial Results

  • Revenue was $39.3 million as compared to $42.9 million in the fiscal first quarter of 2024.
  • Gross profit increased 13.2% to $7.7 million compared to $6.8 million in the fiscal first quarter of 2024.
  • Gross margin increased to 19.5% as compared to 16.0% in the fiscal first quarter of 2024
  • Total operating expenses increased 67.0% to $12.9 million as compared to $7.7 million in the fiscal first quarter of 2024.
  • Net loss of ($5.6) million as compared to net loss of ($1.3) million in the fiscal first quarter of 2024.

Michael Wang, Co-Chief Executive Officer of Ispire, commented, "Our results from the fiscal first quarter of 2025 reflect our commitment to our growth strategy of becoming the leading innovative vaping technology and precision dosing solutions company worldwide. While our financial results were slightly impacted due to the strategic shifts we have made in our US business to focus on high quality customers and to improve payment terms and gross profit, I am pleased with our team's overall performance given the challenging macroeconomic environment and look forward to the remainder of fiscal 2025 and the opportunities that lay ahead."

Mr. Wang continued, "Additionally, we have continued to make progress with the point-of-use age-gating technology and have begun the initial phase of commercialization worldwide.  Also, our recently launched 'I-80' is set to revolutionize the cannabis industry given its production efficiency and cost effectiveness and we continue to see increased adoption of our machine from leading players in the industry. Lastly, we are excited to have recently expanded our global reach through a landmark 5-year master distributor agreement with ANDS for the Middle East and North Affrica region and Global Duty-Free markets. This partnership will enable us to bring our Hidden Hills Club nicotine portfolio to new markets, offering adult consumers innovative, harm-reduced alternatives to combustible cigarettes. We believe that the recent advancements we have made, combined with our solid financial performance, positions Ispire for continued growth and success as we proceed with our mission of providing industry-leading vaping technology worldwide."

Jim McCormick, Chief Financial Officer of Ispire, stated, "The results from our fiscal first quarter were in line with our internal projections as we shifted our U.S. strategy while we also had a few delayed shipments which impacted our quarterly results. Despite the obstacles we've faced, our first quarter financial performance was still strong, including our gross profit increasing 13.2% year-over-year and our gross margins improving from 16.0% in the fiscal first quarter of 2024 to 19.5% in the fiscal first quarter of 2025. As we head into the remainder of fiscal 2025, we are confident that we are well-positioned to continue delivering value to our shareholders as we advance our mission of becoming a global leading provider of innovative vaping technology and precision dosing solutions."

Financial Results for the Fiscal First Quarter Ended September 30, 2024

For the fiscal first quarter ended September 30, 2024, Ispire reported revenue of $39.3 million compared to $42.9 million during the same period last year, a decrease of 8.2%. The decrease in revenue is the combined effect of decreases in product sales in the United States of $8.1 million from $17.8 million for the fiscal first quarter ended September 30, 2023, to $9.7 million for the three months ended September 30, 2024,  offset by increases in sales of vaping products in Europe of $2.1 million from $19.9 million for the three months ended September 30, 2023 to approximately $22.0 million for the fiscal first quarter ended September 30, 2024, and increases in sales to other regions of $3.7 million from $0.06 million for the three months ended September 30, 2023 to approximately $3.8 million for the fiscal first quarter ended September 30, 2024, mainly contributed by increase in sales to South Africa of $2.9 million.

Gross profit for the fiscal first quarter ended September 30, 2024, was $7.7 million compared to $6.8 million for the fiscal first quarter 2024 ended September 30, 2023. Over this same period, our gross margin grew to 19.5%, from 16.0%. The increase in gross profit and gross margin was primarily due to changes in product mix with an increase in higher margin products being sold during the fiscal first quarter ended September 30, 2024.

Total operating expenses for the fiscal first quarter ended September 30, 2024 were $12.9 million as compared to $7.7 million for fiscal first quarter  ended September 30, 2023. The increase in operating expenses is due to an increase in our marketing activities, marketing campaign and trade shows of $0.7 million, stock-based compensation expense related to selling personnel of $1.0 million for the three months ended September 30, 2024 and headcount and payroll expense for Aspire Science of $0.1 million. The Company also had an increase in stock-based compensation expense of $1.0 million for the three months ended September 30, 2024, as compensation and incentive for management, employees and service providers, and an increase in bad debt expense as an allowance for credit losses of $1.9 million from accounts resulted from management's assessment on Company's account receivables balances.

For the fiscal first quarter ended September 30, 2024, net loss was ($5.6) million or ($0.10) per share, compared to a net loss of ($1.3) million, or ($0.02) per share for fiscal first quarter  ended September 30, 2023.

As of September 30, 2024, Ispire had $37.7 million in cash and cash equivalents and working capital of $16.6 million.

Conference Call

The Company will conduct a conference call at 8:00 am Eastern Time on Monday, November 11, 2024, to discuss the results. Ispire management will host the conference call, followed by a question-and-answer period.

Please call the conference call dial-in 5-10 minutes prior to the start time and ask for the "Ispire Technology Call." An operator will register your name and organization.

  • Date: Monday, November 11, 2024
  • Time: 8:00 am ET
  • Dial-In Numbers: United States 844-826-3033 or International +1 412-317-5185

This conference call will be broadcast live on the Internet and can be accessed by all interested parties at  https://viavid.webcasts.com/starthere.jsp?ei=1693594&tp_key=0c7f927f41 

Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software.

A playback will be available from 11:00 am ET on November 11, 2024 through November 25, 2024. To listen, please dial 1-844-512-2921 or 1-412-317-6671. Use the passcode 10193803 to access the replay.

About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 200 patents received or filed globally. Ispire's tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company's cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware only in the U.S., and it recently commenced its marketing activities in Canada and Europe. For more information, visit
www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Facebook, Twitter and YouTube. Any information contained on, or that can be accessed through, the Company's website, any other website or any social media, is not a part of this press release.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be successful in achieving its goals as currently contemplated, with different terms, or at all, the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices, the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE™'s success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets, the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended September 30, 2023 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

 

ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In $USD, except share and per share data)




September 30,
2024



June 30,
2024


Assets







Current assets:







Cash


$

37,731,954



$

35,071,294


Restricted cash



24,280




-


Accounts receivable, net



62,359,322




59,734,765


Inventories, net



6,992,025




6,365,394


Prepaid expenses and other current assets



1,406,822




1,400,152


Total current assets



108,514,403




102,571,605


Other assets:









Property, plant and equipment, net



2,662,714




2,582,457


Intangible assets, net



2,015,805




1,375,666


Right-of-use assets – operating leases



3,295,952




3,579,140


Other investment



2,000,000




2,000,000


Equity method investment



10,172,075




10,248,048


Other non-current assets



291,699




284,050


Total other assets



20,438,245




20,069,361


Total assets


$

128,952,648



$

122,640,966


Liabilities and stockholders' equity









Current liabilities









Accounts payable


$

4,341,642



$

3,779,723


Accounts payable – related party



76,001,622




67,046,472


Contract liabilities



2,245,505




2,218,166


Accrued liabilities and other payables



12,139,232




11,738,339


Income tax payable



399,995




-


Operating lease liabilities – current portion



1,240,726




1,207,832


Total current liabilities



96,368,722




85,990,532











Other liabilities:









Operating lease liabilities – net of current portion



1,869,951




2,194,094


Total liabilities



98,238,673




88,184,626











Commitments and contingencies


















Stockholders' equity:









Common stock, par value $0.0001 per share; 140,000,000 shares authorized;
56,641,041 and 56,470,636 shares issued and outstanding as of September 30,
2024 and June 30, 2024



5,664




5,647


Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, no
shares issued at September 30, 2024 and June 30, 2024



-




-


Additional paid-in capital



45,224,962




43,217,391


Accumulated deficit



(14,420,057)




(8,825,041)


Accumulated other comprehensive (loss) income



(96,594)




58,343


Total stockholders' equity



30,713,975




34,456,340


Total liabilities and stockholders' equity


$

128,952,648



$

122,640,966


 

 

ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In $USD, except share and per share data)




Three Months Ended
September 30,




2024



2023









Revenue


$

39,338,313



$

42,864,647


Cost of revenue



31,663,935




36,019,799


Gross profit



7,674,378




6,844,848


Operating expenses:









Sales and marketing expenses



2,992,247




1,025,219


General and administrative expenses



9,904,539




6,697,874


Total operating expenses



12,896,786




7,723,093


Loss from operations



(5,222,408)




(878,245)


Other income (expense):









Interest income



86




72,246


Exchange gain, net



117,585




3,661


Other income (expenses), net



6,935




(43,204)


Total other income, net



124,606




32,703


Loss before income taxes



(5,097,802)




(845,542)


Income taxes - current



(497,214)




(496,045)


Net loss


$

(5,595,016)



$

(1,341,587)


Other comprehensive (loss) income









Foreign currency translation adjustments                               



(154,937)




44,463


Comprehensive loss



(5,749,953)




(1,297,124)


Net loss per share









Basic and diluted


$

(0.10)



$

(0.02)


Weighted average shares outstanding:









Basic and diluted



56,601,320




54,246,212


 

 

 ISPIRE TECHNOLOGY INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In $USD, except share and per share data)




Three Months ended
September 30,




2024



2023


Net loss:


$

(5,595,016)



$

(1,341,587)


Adjustments to reconcile net income from operations to net cash provided by
operating activities:









Depreciation and amortization



204,807




29,161


Credit loss expenses



3,102,081




225,487


Right-of-use assets amortization



283,188




287,481


Stock-based compensation expenses



2,007,588




967,560


Inventory impairment



73,692




-


Loss from equity method investment



75,973




-


Changes in operating assets and liabilities:









Accounts receivable, net



(5,726,638)




(14,710,476)


Inventories



(700,323)




1,863,080


Other current and non-current assets



(14,319)




1,603,180


Accounts payable



9,517,069




(2,449,276)


Contract liabilities



(87,402)




281,529


Accrued liabilities and other payables



360,697




(124,950)


Income tax payable



399,995




496,138


Lease liabilities



(291,249)




(249,753)


Net cash provided by (used in) operating activities


$

3,610,143



$

(13,122,426)











Cash flows from investing activities:









    Purchase of property, plant and equipment



(268,781)




(533,122)


Acquisition of intangible assets



(656,422)




(255,650)


Net cash used in investing activities


$

(925,203)



$

(788,772)











Cash flows from financing activities:









Repayments of advances from a related party



-




(703,323)


Net cash used in financing activities


$

-



$

(703,323)











Net increase (decrease) in cash and cash equivalents



2,684,940




(14,614,521)


Cash and cash equivalents - beginning of period



35,071,294




40,300,573


Cash and cash equivalents - end of period


$

37,756,234



$

25,686,052











Supplemental non-cash investing and financing activities









Leased assets obtained in exchange for operating lease liabilities



-




537,307


 

For more information, kindly contact:

IR Contacts:
Investor Relations
Sherry Zheng
718-213-7386
ir@ispiretechnology.com

KCSA Strategic Communications
Phil Carlson
212-896-1233
ispire@kcsa.com

PR Contact:
Ellen Mellody
570-209-2947
EMellody@kcsa.com

 

Cision View original content:https://www.prnewswire.com/news-releases/ispire-technology-inc-reports-financial-results-for-fiscal-first-quarter-2025-302300568.html

SOURCE Ispire Technology Inc.

FAQ

What were Ispire Technology's fiscal Q1 2025 revenue results?

Ispire Technology reported fiscal Q1 2025 revenue of $39.3 million, a decrease from $42.9 million in Q1 2024.

How did Ispire Technology's gross profit perform in fiscal Q1 2025?

Gross profit increased 13.2% to $7.7 million in fiscal Q1 2025.

What was Ispire Technology's net loss for fiscal Q1 2025?

Ispire Technology reported a net loss of ($5.6) million or ($0.10) per share for fiscal Q1 2025.

What was the gross margin for Ispire Technology in fiscal Q1 2025?

The gross margin increased to 19.5%, up from 16.0% in fiscal Q1 2024.

What was the impact of the 5-year master distributor agreement announced by Ispire Technology?

Ispire Technology expanded its global reach through a 5-year master distributor agreement with ANDS for MENA and global duty-free markets.

Ispire Technology Inc.

NASDAQ:ISPR

ISPR Rankings

ISPR Latest News

ISPR Stock Data

322.32M
18.17M
67.99%
9.08%
1.19%
Tobacco
Cigarettes
Link
United States of America
LOS ANGELES